A new law in Washington requiring pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C. The SafeRX law, which went into effect April 1, created concern for medical meeting planners who thought that the legislation might have an impact on their meetings. Initially, the law was not clear on how it would affect pharmaceutical sales representatives, also
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.